2877.HK Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 birž. 2024 @ 11:08):
Our systems believe the stock currently is undervalued by 0.01% compare to its pairs and should correct upwards.

Stats
Šios dienos apimtis	1.04M
Vidutinė apimtis	710 572
Rinkos kapitalizacija	5.81B
EPS	HKD0.630 ( Q4 \| 2023-12-31 )
Kita pelno data	( HKD0 ) 2024-08-27
Last Dividend	HKD0.353 ( 2023-04-28 )
Next Dividend	HKD0 ( N/A )
P/E	5.57 (Sector) 0 (Industry) 0
ATR14	HKD0.0290 (0.38%)

0013.HK -0.72%

0239.HK 1.24%

0455.HK 1.96%

0512.HK -0.21%

0570.HK 0.83%

0719.HK 0.75%

0858.HK 2.56%

0867.HK 0.76%

0874.HK 0.24%

0911.HK -1.75%

1011.HK -10.26%

1312.HK 3.03%

1349.HK 0.56%

1498.HK 0.00%

1513.HK 0.78%

1558.HK 5.15%

1652.HK -2.02%

1681.HK 2.58%

2161.HK 5.00%

2196.HK 0.46%

2552.HK 2.70%

2633.HK 1.56%

2877.HK -1.79%

3737.HK 0.00%

6185.HK 0.72%

6896.HK -0.65%

8049.HK -0.76%

8329.HK 3.62%

8622.HK 0.00%

9989.HK 2.52%

Koreliacija (AI algo v.1.1b): Undervalued: 0.01% HKD7.69 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: -0.13 (neutral)

Trumpas: -0.74 (moderate negative)

Signal:(46.593) Neutral

China Shineway Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

China Shineway Koreliacija - Valiuta/Žaliavos

0.18
( neutral )

-0.52
( weak negative )

0.00
( neutral )

-0.08
( neutral )

-0.12
( neutral )

-0.45
( neutral )

China Shineway Finansinės ataskaitos

Annual	2023
Pajamos:	HKD4.52B
Bruto pelnas:	HKD3.39B (75.15 %)
EPS:	HKD1.280

FY	2023
Pajamos:	HKD4.52B
Bruto pelnas:	HKD3.39B (75.15 %)
EPS:	HKD1.280

FY	2022
Pajamos:	HKD3.95B
Bruto pelnas:	HKD2.94B (74.38 %)
EPS:	HKD0.960

FY	2021
Pajamos:	HKD3.22B
Bruto pelnas:	HKD2.41B (74.77 %)
EPS:	HKD0.740

Financial Reports:

No articles found.

China Shineway Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0.125 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.353 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

China Shineway Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.69 - Increase likely (53.75%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.100	2005-09-01
Last Dividend	HKD0.353	2023-04-28
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	36	--
Total Paid Out	HKD5.15	--
Avg. Dividend % Per Year	0.00%	--
Score	4.25	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	7.69
Div. Directional Score	9.62	--

Next Divdend (Est)
(2024-10-10)

HKD0 Estimate 0.00 %

Dividend Stability

0.10 Very Bad

Dividend Score

4.25

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
28 Apr 2023	HKD0.353	30 Nov -0001	30 Nov -0001	30 Nov -0001
13 Sep 2022	HKD0.125	30 Nov -0001	30 Nov -0001	30 Nov -0001
03 May 2022	HKD0.258	30 Nov -0001	30 Nov -0001	30 Nov -0001
13 Sep 2021	HKD0.470	30 Nov -0001	30 Nov -0001	30 Nov -0001
03 Jun 2021	HKD0.248	30 Nov -0001	30 Nov -0001	30 Nov -0001
06 Oct 2020	HKD0.124	30 Nov -0001	30 Nov -0001	30 Nov -0001
04 Jun 2020	HKD0.0983	31 Mar 2020	05 Jun 2020	18 Jun 2020
08 Oct 2019	HKD0.121	30 Aug 2019	09 Oct 2019	30 Oct 2019
04 Jun 2019	HKD0.105	29 Mar 2019	05 Jun 2019	18 Jun 2019
09 Oct 2018	HKD0.126	31 Aug 2018	10 Oct 2018	30 Oct 2018
04 Jun 2018	HKD0.262	29 Mar 2018	05 Jun 2018	15 Jun 2018
10 Oct 2017	HKD0.130	29 Aug 2017	11 Oct 2017	30 Oct 2017
05 Jun 2017	HKD0.101	30 Mar 2017	06 Jun 2017	16 Jun 2017
11 Oct 2016	HKD0.128	26 Aug 2016	12 Oct 2016	28 Oct 2016
02 Jun 2016	HKD0.108	30 Mar 2016	03 Jun 2016	17 Jun 2016
13 Oct 2015	HKD0.133	28 Aug 2015	14 Oct 2015	30 Oct 2015
04 Jun 2015	HKD0.125	27 Mar 2015	05 Jun 2015	19 Jun 2015
14 Oct 2014	HKD0.139	29 Aug 2014	15 Oct 2014	31 Oct 2014
05 Jun 2014	HKD0.125	28 Mar 2014	06 Jun 2014	19 Jun 2014
15 Oct 2013	HKD0.140	30 Aug 2013	16 Oct 2013	31 Oct 2013

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
2360.HK	Ex Dividend Knight	2023-10-03	Annually	0.00%
0636.HK	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%
1857.HK	Ex Dividend Junior	2023-08-23	Semi-Annually	0.00%
0217.HK	Ex Dividend Junior	2023-07-05	Sporadic	0.00%
1286.HK	Ex Dividend Knight	2023-08-21	Semi-Annually	0.00%
3718.HK	Ex Dividend Knight	2023-09-11	Semi-Annually	0.00%
0857.HK	Ex Dividend Knight	2023-09-12	Semi-Annually	0.00%
2111.HK	Ex Dividend Knight	2023-09-13	Annually	0.00%
0393.HK	Ex Dividend Knight	2023-09-14	Semi-Annually	0.00%
1598.HK	Ex Dividend Junior	2023-07-13	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.215	1.500	5.71	8.56	[0 - 0.5]
returnOnAssetsTTM	0.101	1.200	6.62	7.95	[0 - 0.3]
returnOnEquityTTM	0.142	1.500	9.54	10.00	[0.1 - 1]
payoutRatioTTM	0.327	-1.000	6.73	-6.73	[0 - 1]
currentRatioTTM	3.35	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	2.95	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	2.42	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.0315	-1.500	9.48	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	1.229	2.00	9.59	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.039	2.00	9.48	10.00	[0 - 20]
debtEquityRatioTTM	0.0428	-1.500	9.83	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.751	1.000	0.809	0.809	[0.2 - 0.8]
operatingProfitMarginTTM	0.215	1.000	7.70	7.70	[0.1 - 0.6]
cashFlowToDebtRatioTTM	3.10	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.472	0.800	-0.188	-0.151	[0.5 - 2]
Total Score				11.55

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	5.60	1.000	9.54	0	[1 - 100]
returnOnEquityTTM	0.142	2.50	9.70	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.039	2.00	9.65	10.00	[0 - 30]
dividendYielPercentageTTM	8.09	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.229	2.00	9.59	10.00	[0 - 30]
payoutRatioTTM	0.327	1.500	6.73	-6.73	[0 - 1]
pegRatioTTM	13.12	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.206	1.000	7.34	0	[0.1 - 0.5]
Total Score				7.69

China Shineway Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

China Shineway

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers modern Chinese medicines in the form of soft capsules, granules, and injections, as well as TCM Formula Granules in various therapeutic areas, including cardio-cerebrovascular, anti-viral, orthopedics, pediatrics, gynecology, and gastroenterology. It also trades in agricultural products. The company was incorporated in 2004 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.